Table 1 Baseline characteristics of study patients. Data presented as either number (percent) or mean (standard deviation) as appropriate
Total (221) | Faculty (141) | Fellow (80) | p-value | |
|---|---|---|---|---|
Age [years] | 64.8 (13.6) | 67.2 (12.9) | 60.6 (13.7) | <0.001 |
Female (%) | 124 (56) | 91 (64.5) | 33 (41.2) | 0.001 |
Mean BMI [Kg/m2] | 30.4 (7.0) | 30.7 (7.1) | 29.7 (6.9) | 0.14 |
Co-morbidities | ||||
Hypertension (%) | 206 (93.2) | 130 (92.2) | 76 (95) | 0.58 |
Diabetes Mellitus (%) | 146 (66) | 93 (65.9) | 53 (66.3) | 0.9 |
Congestive Heart Failure (%) | 96 (43.4) | 58 (41.1) | 38 (47.5) | 0.39 |
Peripheral Vascular Disease (%) | 33 (14.9) | 23 (16.3) | 10 (12.5) | 0.55 |
Race/ Ethnicity | 0.06 | |||
White (%) | 17 (7.7) | 14 (9.9) | 3 (3.7) | |
African-American (%) | 68 (30.8) | 49 (34.7) | 19 (23.7) | |
Hispanic | 107 (48.4) | 63 (44.7) | 44 (55) | |
Other | 29 (13.1) | 15 (10.6) | 14 (17.5) | |
Primary Language | ||||
English (%) | 164 (74.2) | 108 (76.5) | 56 (70) | 0.3 |
Spanish (%) | 51 (23.2) | 30 (21.3) | 21 (26.2) | 0.4 |
Insurance | ||||
Medicaid (%) | 77 (34.8) | 33 (23.4) | 44 (55) | <0.001 |
Medicare (%) | 70 (31.8) | 54 (38.3) | 16 (20) | 0.006 |
Never smoker (%) | 118 (53.4) | 76 (53.9) | 42 (52.5) | 0.8 |
Hemoglobin, mean (SD) [gm/dL] | 10.7 (1.8) | 10.9 (1.8) | 10.3 (1.8) | 0.04 |
Albumin, mean [gm/dL] | 3.8 (0.6) | 3.96 (0.6) | 3.53 (0.7) | <0.001 |
Creatinine, mean [mg/dL] | 2.88 (1.2) | 2.7 (1.2) | 3.18 (1.2) | 0.005 |
Renal Clinic visit, mean | 5.4 (4.1) | 5.3 (4.2) | 5.5 (4.1) | 0.8 |
eGFR [ml/min/1.73 m2] at the study entry, median (IQR) | 20.8 (6.4) | 21.3 (6.2) | 19.8 (6.5) | 0.07 |
Urine albumin/creatinine ratio | 0.78 (0.18, 3.73) | 0.51 (0.13, 2.08) | 2.64 (0.44, 5.31) | <0.001 |
Follow up (years), median (IQR) | 1.26 (0.6–1.68) | 1.3(0.75–1.69) | 1.2 (0.4–1.6) | 0.1 |
Any hospitalization | 155 (70.1) | 89 (63.1) | 66 (82.5) | 0.002 |
Any hospitalization with acute kidney injury episode | 136 (61.5) | 74 (52.5) | 62 (77.5) | <0.001 |